Advaxis, Inc.

Advaxis is a Princeton-based life sciences company that develops immunotherapies to combat various forms of cancer, including human papillomavirus (HPV)-associated cancers, prostate cancer and certain aggressive types of cancerous solid tumors.

Advaxis was a graduate of the Commercialization Center for Innovative Technologies (CCIT) and also benefited from the  Technology Business Tax Certificate Transfer (NOL) Program.